Intravitreal Bioavailability is the fraction of an ophthalmic drug that reaches the vitreous humor in an active form following administration, distinguishing it from other ocular bioavailability pathways by its direct measurement of drug availability at the intravitreal site of action.
131
Publications
7K
Citations
698
Authors
253
Institutions
Publications per year
2017–2026
30
Parents
Publications
131
The Clearance of Intravitreal Triamcinolone Acetonide
Reinhardt H. Schindler, David Chandler, Randy Thresher et al. · American Journal of Ophthalmology · 1982 · 209 citations
1–5 of 131
Authors
698
- GA
4
h-index
- MM
4
h-index
- LC
4
h-index
- SM
4
h-index
- RG
4
h-index
1–5 of 698
Institutions
253
University of Illinois Chicago
Chicago, United States
5 h-index
24 publications
727 citations
Heidelberg University
Heidelberg, Germany
4 h-index
11 publications
419 citations
University of California San Diego
San Diego, United States
4 h-index
10 publications
309 citations
Inserm
Paris, France
4 h-index
13 publications
1K citations
Sun Yat-sen University
Guangzhou, China
4 h-index
9 publications
386 citations
Centre National de la Recherche Scientifique
Paris, France
3 h-index
11 publications
958 citations
University of Eastern Finland
Joensuu, Finland
3 h-index
18 publications
675 citations
Johns Hopkins Medicine
Baltimore, United States
3 h-index
4 publications
133 citations
1–8 of 253
Venues
- American Journal of Ophthalmology
12 publications · 1.3K citations
12
h-index
- Investigative Ophthalmology & Visual Science
IOVS · 11 publications · 1.1K citations
11
h-index
- Retina
8 publications · 414 citations
8
h-index
- PubMed
Repository · 7 publications · 361 citations
7
h-index
- Ophthalmology
7 publications · 326 citations
7
h-index
1–5